Protagonist Therapeutics, Inc.
NASDAQ:PTGX
45.62 (USD) • At close April 29, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 275.188 | -78.955 | -127.393 | -125.551 | -66.15 | -77.187 | -38.924 | -36.957 | -37.177 | -14.858 | -11.072 |
| Afschrijvingen & Amortisatie
| 2.895 | 3.312 | 3.369 | 2.775 | 2.564 | 2.495 | 0.527 | 0.406 | 0.317 | 0.247 | 0.258 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 1.438 | -0.775 | -0.658 | 0 | 0.151 | -0.008 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 37.554 | 29.293 | 24.202 | 16.395 | 7.899 | 8.353 | 6.919 | 4.241 | 2.13 | 0.099 | 0.042 |
| Verandering in Werkkapitaal
| 0 | -19.511 | -7.766 | -3.314 | -19.016 | 26.144 | -18.017 | 35.557 | -0.112 | 0.052 | 1.26 |
| Vorderingen
| 0 | 0 | 4.242 | -0.915 | 3.339 | -0.757 | -2.771 | -1.816 | -1.588 | -0.192 | 0 |
| Voorraden
| 0 | 0 | -4.242 | 0.915 | -3.339 | 0.757 | 3.853 | 5.53 | 0 | 0 | 0 |
| Crediteuren
| 0.842 | -2.934 | 2.045 | -1.39 | 0.309 | -3 | 4.43 | 0.091 | -0.115 | 0.898 | 0.179 |
| Overig Werkkapitaal
| 0 | -16.577 | -9.811 | -1.924 | -19.325 | 29.144 | -23.529 | 31.752 | 0.003 | -0.846 | 1.081 |
| Overige Niet-Contante Posten
| -131.485 | -4.375 | -0.549 | 1.83 | 0.781 | -0.557 | 0.206 | 0.625 | 4.719 | 0.083 | 1.769 |
| Kasstroom uit Operationele Activiteiten
| 184.152 | -70.236 | -108.137 | -107.865 | -72.484 | -41.527 | -49.947 | 3.872 | -29.972 | -14.385 | -7.743 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -1.355 | -0.609 | -0.795 | -1.101 | -0.471 | -0.967 | -0.486 | -0.666 | -0.379 | -0.399 | -0.299 |
| Netto Overnames
| 0 | 0 | -91.468 | 14.759 | 90.494 | 52.743 | 0 | 0 | 0.032 | 0 | 0 |
| Aankoop van Beleggingen
| -621.702 | -191.045 | -214.874 | -286.589 | -280.027 | -166.936 | -71.06 | -39.546 | -73.169 | -7.865 | 0 |
| Verkoop/verval van Beleggingen
| 323.574 | 152.396 | 307.137 | 271.83 | 189.533 | 114.193 | 73.759 | 56.035 | 14.188 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 91.468 | -14.759 | -90.494 | -52.743 | 2.699 | 16.489 | 0.032 | -7.865 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -299.483 | -39.258 | 91.468 | -15.86 | -90.965 | -53.71 | 2.213 | 15.823 | -59.328 | -8.264 | -0.299 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | -10.524 | 9.765 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 132.1 | 14.553 | 123.829 | 255.365 | 34.492 | 23.181 | 64.547 | 83.648 | 17.419 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 25.853 | 38.377 | 4.285 | 6.094 | 2.785 | 1.779 | 0.934 | 1.007 | 22.659 | 17.419 | 9.003 |
| Kasstroom uit Financieringsactiviteiten
| 25.853 | 170.477 | 18.838 | 129.923 | 247.626 | 46.036 | 24.115 | 65.554 | 106.307 | 17.419 | 9.003 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | -0.09 | -0.126 | 0.175 | -0.026 | -0.177 | 0.146 | 0.022 | -0.039 | -0.097 |
| Netto Kasstroomverandering
| -89.478 | 60.983 | 2.079 | 6.072 | 84.352 | -49.227 | -23.796 | 85.395 | 17.029 | -5.269 | 0.864 |
| Kaspositie aan het Einde van de Periode
| 97.474 | 186.952 | 125.969 | 123.89 | 117.818 | 33.466 | 82.693 | 106.489 | 21.084 | 4.055 | 9.324 |